Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 19
Gene Symbol: ABCA1
ABCA1
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 AlteredExpression BEFREE These results indicate that the cholesterol trafficking defect in NPC disease results in reduced activity of ABCA1, which we suggest is responsible for the low HDL-cholesterol in the majority of NPC subjects and partially responsible for the overaccumulation of cellular lipids in this disorder. 12813037

2003

Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 AlteredExpression BEFREE Regardless of the differentiation status, PDT tested NPC cell lines all expressed P-gp protein. 25900553

2015

Entrez Id: 4363
Gene Symbol: ABCC1
ABCC1
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.020 AlteredExpression BEFREE The expression of FBW7 and MRP was detected by Western blotting after siRNA interference in the CDDP-resistant NPC cell line, CNE2-CDDP. 25586348

2015

Entrez Id: 4363
Gene Symbol: ABCC1
ABCC1
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.020 Biomarker BEFREE In this study, using MRP overexpressing multidrug resistant nasopharyngeal cancer cells, we examined the expression of apoptosis related genes including p53, p21WAF1, bax and bcl-Xs between drug sensitive KB and its resistant KB/7D cells. 10762632

2000

Entrez Id: 1244
Gene Symbol: ABCC2
ABCC2
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 Biomarker BEFREE Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin. 18834541

2008

Entrez Id: 8714
Gene Symbol: ABCC3
ABCC3
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 AlteredExpression BEFREE FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein. 25586348

2015

Entrez Id: 10057
Gene Symbol: ABCC5
ABCC5
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 Biomarker BEFREE Small molecular inhibitors of FOXM1 or ABCC5 have the potential to overcome paclitaxel chemoresistance in NPC patients. 28277541

2017

Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.050 AlteredExpression BEFREE Consistently, an inverse correlation was observed between the mRNA levels of IRF6 and ABCG2 in clinical NPC samples. 29111349

2018

Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.050 Biomarker BEFREE The expression of c-Myc and ABCG2 was higher in <i>RARS-MAD1L1</i>-positive HNC samples than in negative samples.<b>Conclusions:</b> Our findings indicate that RARS-MAD1L1 might contribute to tumorigenesis, CSC-like properties, and therapeutic resistance, at least in part, through the FUBP1/c-Myc axis, implying that <i>RARS-MAD1L1</i> might serve as an attractive target for therapeutic intervention for NPC.<i></i>. 29133573

2018

Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.050 AlteredExpression BEFREE Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma. 26081022

2015

Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.050 AlteredExpression BEFREE More importantly, the endogenous expression of LMP2A positively correlates with the expression of ABCG2 in NPC samples. 20532215

2010

Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.050 Biomarker BEFREE Our data demonstrated that there exist ABCG2⁺ cells in NPC cells, but ABCG2 alone is not sufficient for isolating cancer stem cells in 5-8F NPC cells. 22209971

2012

Entrez Id: 25
Gene Symbol: ABL1
ABL1
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 GeneticVariation BEFREE The Abelson murine leukaemia (ABL) gene at 9q34 was targeted in this study as 9q34 is a common region of loss in NPC. 29914565

2018

Entrez Id: 28
Gene Symbol: ABO
ABO
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.130 Biomarker BEFREE <b>Purpose</b>: To identify the association between ABO blood type and the survivals in nasopharyngeal carcinoma patients. 30854139

2019

Entrez Id: 28
Gene Symbol: ABO
ABO
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.130 Biomarker BEFREE The prognostic value of ABO blood group may be limited for patients with NPC in the era of IMRT, and no substantial correlation between ABO blood group and plasma EBV DNA was observed. 27835689

2016

Entrez Id: 28
Gene Symbol: ABO
ABO
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.130 Biomarker BEFREE There was no significant difference in age, smoking, family history, and ABO blood group between patients with NPC and the control group (P > 0.05). 29970653

2018

Entrez Id: 1636
Gene Symbol: ACE
ACE
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.020 Biomarker BEFREE <b>Objectives</b>: To evaluate the prognostic significance of Adult Comorbidity Evaluation-27 (ACE-27) for elderly patients (age ≥70 years) with locoregionally advanced nasopharyngeal carcinoma (NPC) treated with Intensity-Modulated Radiotherapy (IMRT), with or without chemotherapy. 31737097

2019

Entrez Id: 1636
Gene Symbol: ACE
ACE
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.020 GeneticVariation BEFREE This finding indicates that the ACE I/D polymorphism may not play a role in susceptibility to NPC. 22064901

2012

Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 AlteredExpression BEFREE Compared to NPC patients with low-grade (stage I-II) tumor node metastasis (TNM) and those without lymph node metastasis, the expression of CXCR4, CXCR7, and CXCL12 were significantly higher in NPC patients with high-grade (stage III-IV) TNM and those with lymph node metastasis (P < 0.05). 26715277

2016

Entrez Id: 51554
Gene Symbol: ACKR4
ACKR4
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 AlteredExpression BEFREE In conclusion, the loss of ACKR4 promoted CCL21-mediated NPC development; thus, neutralizing CCL21 in NPC with low ACKR4 expression may be a novel treatment strategy. 30651842

2019

Entrez Id: 60
Gene Symbol: ACTB
ACTB
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.030 GeneticVariation BEFREE Using stably transfected MTA1 knockdown or overexpression cells, we discovered the function of MTA1 in actin cytoskeleton reorganization and metastasis processing of NPC in this study. 23618874

2013

Entrez Id: 60
Gene Symbol: ACTB
ACTB
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.030 AlteredExpression BEFREE Using microarray analysis, we also found a reduction in expression of key actin dynamics regulators and several epithelial-to-mesenchymal transition-related genes in G(alpha)(12)-depleted NPC cells. 19602597

2009

Entrez Id: 60
Gene Symbol: ACTB
ACTB
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.030 Biomarker BEFREE The EBV-DNA level in NPC tumor (27.8 copies/actin) was significantly higher than that in nasopharyngitis and was positively correlated to the ratio of EBER1-positive cells on the NPC section (p = 0.001). 15736452

2005

Entrez Id: 94
Gene Symbol: ACVRL1
ACVRL1
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.010 Biomarker BEFREE A survival analysis revealed that ALK1 (Disease Free Survival (DFS): P = 0.002, Overall Survival (OS): P = 0.007) and TGFβR2 (DFS: P = 0.072, OS: P = 0.045) could predict the prognosis of NPC patients. 22391627

2012

Entrez Id: 6868
Gene Symbol: ADAM17
ADAM17
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
0.020 Biomarker BEFREE LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. 31810117

2020